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Previewsimpaired FRC maturation on antiviral
immunity, the authors compared sys-
temic lymphocytic choriomeningitis virus
(LCMV) as well as cerebral murine hepati-
tis virus (MHV) infection in Ccl19-
crexLtbrfl/fl and plt/plt mice, a naturally
occurring mutant that lack CCL19 and
CCL21 expression in LN. In both models,
Ccl19-crexLtbrfl/fl mice were more
severely affected than plt/plt mice by the
infection, indicating that immune effector
functions other than those mediated by
CCL19 and CCL21 contribute to impaired
antiviral immunity in LNs lacking mature
FRCs (Chai et al., 2013).
The observations by Chai et al. (2013)
give new insights to our understanding
of LTbR signaling in mesenchymal
stromal cells for LN organogenesis and
the subsequent maturation of myofibro-
blastic progenitors to mature FRCs. The
new mouse models will be helpful to
further study FRC differentiation and
address the question whether thesecells derive directly from LTo cells or
whether LTo cells and FRCs share com-
mon or distinct mesenchymal progenitors
(Figure 1). Likewise, additional studies
are needed to further characterize the
mechanisms that allow mature FRCs
to efficiently contribute to antiviral immu-
nity as immunologically active cells.
Because Ccl19-driven ablation of LTbR
has no effect on LN anlagen formation
and subsequent fetal LN development,
future experimental strategies should
focus on the identification of both the
time window and the cells that rely on
LTbR signals for unimpaired LN organo-
genesis. Such studies will help to further
uncover players that orchestrate the
organizers.
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In this issue of Immunity, Py et al. (2013) report that upon bacterial infection, a fragment of the matrix protein
cochlin is released from the conduits of B cell follicles to trigger protective cytokines in the periphery.Secondary lymphoid organs (SLOs) are
linked into the two fluid transport systems
of mammals and serve as filters where
washed-up pathogenic factors are trap-
ped and examined by immune cells.
Lymph nodes clean the interstitial fluid
by connecting to the lymphatic vessels
while the spleen services the blood circu-
lation. Although SLOs primarily serve
adaptive immunity, they also have impor-
tant innate functions. These are mainly
associated with the subcapsular sinus of
the lymph node and the marginal zone of
the spleen. Both are directly exposed to
the fluid phase with all its potentially path-
ogenic substances and endogenous sig-
nals. In these prefilters, innate cells cap-
ture particles to either directly eliminatethem or to physically carry them into the
parenchyma where they are presented
or passed on to other cells (Batista and
Harwood, 2009).
In contrast to the sinuses, where even
large particles percolate through the
wide interstitial space, the T and B zones
are largely shielded from the body fluids.
Here, only small solutes below 70 kD
have access. And even these do not
directly bathe the lymphocytes but
exclusively trickle through a highly
specialized interstitial compartment,
the conduit system (Gretz et al., 2000).
Conduits are constituted by nonhemato-
poietic cells, which form a web of deli-
cate and highly interconnected tubules.
Each tubule consists of a core of fibrillarextracellular matrix, which is enwrapped
by a basement membrane, which is
again enveloped by the stroma cells
(Gretz et al., 1997). The conduit system
is not tightly sealed and both resident
dendritic cells and B cells continuously
read out the state of lymph and blood
by sampling their content. Once filtered
through the conduits, the bulk fluid is
directly released back into the blood
circulation, establishing a fluid-shunt
between lymph and blood at the level
of the draining lymph node.
Although the functional relevance of the
conduit system is still poorly investigated,
at least three immunological functions
have been proposed: (1) Conduits deliver
soluble antigens to resident dendritic cells38, May 23, 2013 ª2013 Elsevier Inc. 853
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Figure 1. Amplification of Peripheral Innate
Immune Response by the Release of the
LCCL Domain of Cochlin Protein from SLO
Conduits into the Blood
In response to bacterial infection of the lung, LPS
and/or tumor necrosis factor-a (TNF-a) signal in
the SLOs where they induce aggrecanase. Aggre-
canase cleaves the LCCL domain of the extracel-
lular matrix protein cochlin, which is found in B
cell follicle conduits, and which is homeostatically
secreted by follicular dendritic cells. Via the
conduits, the LCCL fragment is released into the
blood to act at the primary site of infection (in this
case, the lung) by increasing the secretion of
inflammatory cytokines and enhancing leukocyte
recruitment.
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Previewsand B cells. Such antigens might then
be presented to induce immunity or toler-
ance (Itano and Jenkins, 2003; Roozen-
daal et al., 2009; Sixt et al., 2005). (2) Con-
duits deliver chemokines from the
periphery to the lumen of high endothelial
venules, where they enhance lymphocyte
recruitment (Palframan et al., 2001). (3)
Conduits deliver cytokines from the pe-
riphery into the parenchyma, where they
might signal to resident cells (Gretz
et al., 2000; Nolte et al., 2003).
Notably all these potential immunolog-
ical functions are input functions where
the cells within SLOs receive information,
which is generated in the periphery or in
the sinuses. Py et al., (2013) now add a
new layer of functionality: an output func-
tion of the conduits where an inflamma-
tory mediator is released from the conduit
into the circulation to act as a global signal
to boost antibacterial immunity (see
Figure 1).
The authors began by characterizing
the function of the extracellular matrix854 Immunity 38, May 23, 2013 ª2013 Elsevicomponent cochlin. Cochlin is a highly
conserved protein with two von Wille-
brand factor A-like domains (vWFA) that
presumably couple it to other interstitial
matrix components and an LCCL domain
with strong homology to the Limulus
factor C, a protein involved in the amplifi-
cation cascade that drives the pyrogen
response of the horseshoe crab. The
only function of cochlin known to date
was in the inner ear, where cochlin is the
main noncollagenous matrix component
and dominant mutations cause forms of
inherited progressive deafness (Robert-
son et al., 2008).
Py et al. found that cochlin specifically
localizes to the conduits of B cell follicles
in spleen and lymph node. Here it is asso-
ciated with follicular dendritic cells, which
also produce the molecule when cultured
in vitro. Cochlin is a component of
conduits that is specific for the B cell
area conduits and cannot be found in
the T cell area. In response to infection
or LPS injection, the authors show that
the proteolytic enzyme aggrecanase-2 is
induced in the B cell follicles and that
aggrecanase cleaves the LCCL domain
off the two vWFA domains. After cleav-
age, LCCL is released into the blood
circulation while the vWFA domains are
left in the conduit. In the circulation, the
LCCL domains were detected as two
differentially glycosylated polypeptides,
which, via unknown pathways, signal to
innate immune cells in the periphery and
amplify cytokine responses. This cascade
of events seems to protect the organism
against bacterial threats because the
authors show that cochlin-deficient mice
suffer reduced survival in response to
Staphylococcus and Pseudomonas infec-
tions. The same was true when aggra-
canase was inhibited and the disease
aggravating effect of aggrecanase inhibi-
tion was partly dependent on the pres-
ence of cochlin. Interestingly, the authors
could not find any indications that cochlin
deficiency also affected adaptive immune
responses. This assigns a unique function
to follicular dendritic cells, which until
now were mainly known for their function
in driving B cell responses, especially
germinal center reactions. Because they
seem to be the cells that produce cochlin
and possibly also trigger the release of
the cochlin fragments into the periphery,
follicular dendritic cells may act as local
amplifiers of innate immune responses.er Inc.The proposed mechanism of signal distri-
bution somewhat resembles acute phase
responses, where a local cytokine signal
is amplified in the liver, which then sends
an endocrine signal to the whole organ-
ism. SLO conduits appear as the perfect
sites for such a signal relay because all
immunologically relevant signaling mole-
cules are funneled through their lumen,
while their content is directly drained into
the blood circulation.
This work identifies a signal distributor
function of the conduit system and the
release of cochlin fragments might only
be one aspect of a whole new operational
principle. It is very likely that the lumen of
the conduit system harbors a large
amount of cytokines. For example, the
conduit carries dense arrays of heparan
sulfate and other charged residues to
potentially immobilize immunoactive fac-
tors. Because most of the extracellular
signaling molecules bind to connective
tissue, the conduit might be a potent store
for factors, which can be quickly released
into the circulation to act as global signals.REFERENCES
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